Healthcare >> CEO Interviews >> October 1, 2001
CHRISTOPHER A. KUEBLER, the Chairman and Chief Executive Officer of
Covance, Inc., spearheaded the company's spin-off from Corning
Incorporated and created one of the world's largest and most
comprehensive contract drug development services companies. In 2000, the
company had revenues of $868 million, operations in more than 17
countries, and 7,900 employees worldwide. Mr. Kuebler joined Covance,
formerly Corning Pharmaceutical Services, as the company's President and
Chief Executive Officer in 1994. Under Mr. Kuebler's leadership, the
company has expanded geographically and operationally, enhanced its
capabilities, and integrated its businesses around the world. Today,
Covance offers its clients a broad array of services at all points in
the entire drug development process ' from preclinical testing through
clinical trials management and periapproval studies. Prior to joining
Covance, Mr. Kuebler spent nearly 20 years in the pharmaceutical
industry. Most recently he held positions of increasing responsibility
at Abbott Laboratories in the company's domestic pharmaceutical division
including Business Unit Director, Vice President of Marketing, and Vice
President of Marketing and Sales. During his last two years at Abbott,
he served as Corporate Vice President of Abbott Europe. Mr. Kuebler
began his career in the pharmaceutical industry in 1975 in various sales
and marketing management positions for E.R. Squibb and Sons, now part of
Bristol-Myers Squibb. From 1982 to 1985, he worked at Monsanto Health
Care as part of the company's pharmaceutical acquisition team. Mr.
Kuebler has served as a Board member of the National Pharmaceutical
Council and a member of the Pharmaceutical Research and Manufacturers
Association Marketing Steering Committee. He is currently a member of
the advisory committee of PNC Bancorp. Mr. Kuebler holds a Bachelor of
Science degree in Biological Science from Florida State University. He
is an accomplished scuba diver and deep-sea fisherman. A resident of
Pennsylvania, he is married, and has three daughters. Profile
over the last year or so that investors should focus on?
Mr. Kuebler: During the last year there has been a lot of
